Sinopharm Group Co Ltd
01099: XHKG (HKG)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
HK$15.80 | Vvvhz | Dnzhpzp |
Sinopharm: Reinitiating Coverage on the Largest Chinese Medical Distributor
We reinitiate coverage of China’s largest pharmaceutical distributor Sinopharm, with a narrow moat rating and fair value estimate of HKD 30.70 per share. We think Sinopharm is undervalued, trading at a 32% discount to our fair value.